Amrex Electrotherapy
Generated 5/9/2026
Executive Summary
Amrex Electrotherapy is a privately held US medical device company based in Irvine, California, founded in 1990. The company specializes in manufacturing electrotherapy, ultrasound, and diathermy equipment for pain management and muscle rehabilitation. With a long history in the industry, Amrex focuses on delivering affordable, high-quality therapeutic solutions to healthcare providers. Despite its established presence, the company operates with limited public visibility and has not disclosed funding rounds or valuation. Its product portfolio addresses a consistent demand for non-invasive pain relief and rehabilitation devices, but growth prospects hinge on product innovation and market expansion. Given the competitive landscape dominated by larger players, Amrex's ability to differentiate through cost-effective offerings remains key. The company's private status and lack of recent financial or clinical milestones make conviction moderate.
Upcoming Catalysts (preview)
- TBDLaunch of Next-Generation Electrotherapy Device60% success
- TBDFDA 510(k) Clearance for New Diathermy Product70% success
- TBDStrategic Distribution Partnership Expansion50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)